Clinical Trial Update: Early transfusIon of Convalescent Plasma in Elderly COVID-19 Patients. to Prevent Disease Progression. [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on early transfusion of convalescent plasma in elderly COVID-19 patients to prevent disease progression; study phases include Phase 2 and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Disease 2019

Drugs mentioned

• Convalescent Plasma (convalescent plasma)

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Coronavirus Disease 2019 )COVID-19) | Phase 2, Phase 3 | Status: COMPLETED